Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2003
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070233A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070191A2 Tamper-resistant transdermal opioid delivery devices
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003WO2003070167A2 Therapeutic and prophylactic treatment of aging and disorders of aging in humans
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003049744B1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
08/28/2003WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2
08/28/2003WO2003045315A3 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/28/2003WO2003037384A3 Polymer conjugates of protein kinase c inhibitors
08/28/2003WO2003030931A3 Vaccine against arthropod-borne infectious diseases
08/28/2003WO2003029169A3 Hydroxypropylamines
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2003027116A3 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2003015693A3 Screening and therapeutic methods for promoting wakefulness and sleep
08/28/2003WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2003002058A3 Bone anabolic compounds and methods of use
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002074293A3 Methods for restoring cognitive function following systemic stress
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002040451A3 Lactam compound
08/28/2003WO2002040032A3 Cytoprotective estrogen derivatives
08/28/2003WO2002040005A3 Blockade of sodium channels by phenol derivatives
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002026244A3 Compositions and methods of use for extracts of rutaceae plants
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002002780A3 Human serine-threonine kinase
08/28/2003WO2002002190A3 Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003WO2001082949A3 Method of reducing side effects of chemotherapy in cancer patients
08/28/2003WO2001077167A3 Methods of investigating, diagnosing, and treating amyloidosis
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162969 Process and intermediates for pyridazinone antidiabetic agents
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162825 D-amino acid oxidase inhibitors for learning and memory
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162804 Tertiary amines such as N-allyloxyethyl-1,2,3,4,5,6-hexahydro -6,11,11-trimethyl-2,6- methano-3-benzazocin-10-ol and salts, administered as sodium channel modulators for prophylaxis of arrhythmias, spasms or epilepsy
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162791 Phenylpiperazines
08/28/2003US20030162789 4-alkylpiperazine substituted phenol derivative or 4-alkylamide substituted phenols for treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia and Huntinton's disease
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162783 Method and composition for the treatment of pain
08/28/2003US20030162782 Treating a patient suffering from neuropathy with sidenafil, free of 5-(3-pyridyl)pyrazoleo(4,3-d)pyrimidine-7-one, 2-(3-pyridyl)-4a,5-dihydroimidazo(5,1-f)(1,2,4)triazine-4(3H)-one or 2-phenylpurine-6-one, all are substituted
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162771 Have an antagonistic activity with respect to corticotropin releasing factor
08/28/2003US20030162770 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162765 Use in treatment and prevention of central nervous system and other disorders
08/28/2003US20030162756 For delaying or preventing conversion of mild cognitive impairment into dementia, especially Alzheimer's Disease
08/28/2003US20030162749 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
08/28/2003US20030162705 Liver extract
08/28/2003US20030162704 Method of treatment of parkison's disease with a protein extractable from mammalian organs
08/28/2003US20030162701 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
08/28/2003US20030162700 Central nervous system disorders; antiinflammatory agents; autoimmune disease; leukemia inhibitory factor
08/28/2003US20030162290 Method for inducing differentiation of embryonic stem cells into functioning cells
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162225 Ligands specific for an isoform of the prion protein
08/28/2003US20030162206 Central nervous system disorders; antiinflammatory agnets; antidiabetic agents
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161846 Oral administration of an emulsion pre-concentrate of a nitrogen oxide-releasing NSAID, a surfactant, and an oil or fat; forms an oil-in-water emulsion with gastrointestinal fluids; side- effect reduction; bioavailability
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161814 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
08/28/2003CA2477321A1 Absorption enhancing agent
08/28/2003CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2477116A1 Pyrrolopyrimidine derivatives
1 ... 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 ... 1833